ASHLEY CLARK: Open Payments
NPI 1588171904 · OVIEDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 11 payments from 9 companies in 2025. Trend: 2023 $550 · 2024 $500 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $267 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Lucid Diagnostics Inc. | 2 | $140 |
| Gilead Sciences, Inc. | 1 | $130 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $123 |
| GENZYME CORPORATION | 1 | $120 |
| Phathom Pharmaceuticals, Inc. | 1 | $116 |
| Ardelyx, Inc. | 1 | $105 |
| ABBVIE INC. | 1 | $16 |
Products named: TREMFYA, REZDIFFRA, Livdelzi, XIFAXAN, DUPIXENT, VOQUEZNA, IBSRELA, CREON.
Industry payments across FL — which companies pay providers there.
